Brought to you by 
Cellerix raises €27.2mm through its Series B round
23 Oct 2007
Executive Summary
Cellerix (cell therapies) has raised €27.2mm ($38.31mm) through the closing of its Series B venture round. LSP and Ventech led the round and were joined by fellow new investors Ysios Capital Partners, Roche Venture Fund, and Novartis Venture Fund as well as current backers Genetrix SL, Grupo A&G, Jose Antonio Matji, and Cellerix management.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cellerix raises €27.2mm through its Series B round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice